Hypoglycaemia frequency and physiological response after double or triple doses of once-weekly insulin icodec vs once-daily insulin glargine U100 in type 2 diabetes: a randomised crossover trial

[1] Gonder-Frederick L(2013)Fear of hypoglycemia: a review Diabetic Hypoglycemia 5 3-11

[2] Okemah J(2018)Addressing clinical inertia in type 2 diabetes mellitus: a review Adv Ther 35 1735-1745

[3] Peng J(2020)Hypoglycemia in patient with type 2 diabetes treated with insulin: it can happen BMJ Open Diabetes Res Care 8 e001194-1021

[4] Quiñones M(2022)Basal weekly insulins: the way of the future! Metabolism 126 154924-733

[5] Heller SR(2003)Hypoglycaemia in insulin-treated type 2 diabetes: frequency, symptoms and impaired awareness Diabet Med 20 1016-49

[6] Peyrot M(2002)Hypoglycemia-associated autonomic failure in advanced type 2 diabetes Diabetes 51 724-8950

[7] Oates SK(2018)Hypoglycemia among patients with type 2 diabetes: epidemiology, risk factors, and prevention strategies Curr Diab Rep 18 53-2116

[8] Taylor AD(2014)Insulin degludec is not associated with a delayed or diminished response to hypoglycaemia compared with insulin glargine in type 1 diabetes: a double-blind randomised crossover study Diabetologia 57 40-1594

[9] Rosenstock J(2021)Molecular engineering of insulin icodec, the first acylated insulin analog for once-weekly administration in humans J Med Chem 64 8942-1603

[10] Del Prato S(2021)Molecular and pharmacological characterization of insulin icodec: a new basal insulin analog designed for once-weekly dosing BMJ Open Diabetes Res Care 9 e002301-705

[1] Gonder-Frederick L(2013)Fear of hypoglycemia: a review Diabetic Hypoglycemia 5 3-11

[2] Okemah J(2018)Addressing clinical inertia in type 2 diabetes mellitus: a review Adv Ther 35 1735-1745

[3] Peng J(2020)Hypoglycemia in patient with type 2 diabetes treated with insulin: it can happen BMJ Open Diabetes Res Care 8 e001194-1021

[4] Quiñones M(2022)Basal weekly insulins: the way of the future! Metabolism 126 154924-733

[5] Heller SR(2003)Hypoglycaemia in insulin-treated type 2 diabetes: frequency, symptoms and impaired awareness Diabet Med 20 1016-49

[6] Peyrot M(2002)Hypoglycemia-associated autonomic failure in advanced type 2 diabetes Diabetes 51 724-8950

[7] Oates SK(2018)Hypoglycemia among patients with type 2 diabetes: epidemiology, risk factors, and prevention strategies Curr Diab Rep 18 53-2116

[8] Taylor AD(2014)Insulin degludec is not associated with a delayed or diminished response to hypoglycaemia compared with insulin glargine in type 1 diabetes: a double-blind randomised crossover study Diabetologia 57 40-1594

[9] Rosenstock J(2021)Molecular engineering of insulin icodec, the first acylated insulin analog for once-weekly administration in humans J Med Chem 64 8942-1603

[10] Del Prato S(2021)Molecular and pharmacological characterization of insulin icodec: a new basal insulin analog designed for once-weekly dosing BMJ Open Diabetes Res Care 9 e002301-705